GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Cyclically Adjusted Price-to-FCF

Sysmex (TSE:6869) Cyclically Adjusted Price-to-FCF : 71.03 (As of May. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex Cyclically Adjusted Price-to-FCF?

As of today (2024-05-27), Sysmex's current share price is 円2695.50. Sysmex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was 円37.95. Sysmex's Cyclically Adjusted Price-to-FCF for today is 71.03.

The historical rank and industry rank for Sysmex's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:6869' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 59.05   Med: 88.86   Max: 149.58
Current: 70.26

During the past years, Sysmex's highest Cyclically Adjusted Price-to-FCF was 149.58. The lowest was 59.05. And the median was 88.86.

TSE:6869's Cyclically Adjusted Price-to-FCF is ranked worse than
73.16% of 231 companies
in the Medical Devices & Instruments industry
Industry Median: 44.14 vs TSE:6869: 70.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sysmex's adjusted free cash flow per share data for the three months ended in Mar. 2024 was 円18.642. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円37.95 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sysmex Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sysmex's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cyclically Adjusted Price-to-FCF Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.86 123.54 84.08 75.36 70.13

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.36 83.84 61.08 69.74 70.13

Competitive Comparison of Sysmex's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Sysmex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sysmex's Cyclically Adjusted Price-to-FCF falls into.



Sysmex Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sysmex's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2695.50/37.95
=71.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sysmex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sysmex's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=18.642/107.2000*107.2000
=18.642

Current CPI (Mar. 2024) = 107.2000.

Sysmex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.153 98.000 1.261
201409 13.603 98.500 14.804
201412 4.305 97.900 4.714
201503 16.397 97.900 17.955
201506 -3.662 98.400 -3.989
201509 16.340 98.500 17.783
201512 2.581 98.100 2.820
201603 16.237 97.900 17.779
201606 -6.057 98.100 -6.619
201609 15.171 98.000 16.595
201612 -2.361 98.400 -2.572
201703 15.176 98.100 16.584
201706 8.112 98.500 8.828
201709 13.099 98.800 14.213
201712 8.649 99.400 9.328
201803 12.448 99.200 13.452
201806 -2.064 99.200 -2.230
201809 11.537 99.900 12.380
201812 6.718 99.700 7.223
201903 8.958 99.700 9.632
201906 3.358 99.800 3.607
201909 17.917 100.100 19.188
201912 3.289 100.500 3.508
202003 18.040 100.300 19.281
202006 5.363 99.900 5.755
202009 12.760 99.900 13.692
202012 15.672 99.300 16.919
202103 15.703 99.900 16.850
202106 11.223 99.500 12.092
202109 26.633 100.100 28.522
202112 3.999 100.100 4.283
202203 0.640 101.100 0.679
202206 -8.054 101.800 -8.481
202209 24.542 103.100 25.518
202212 0.276 104.100 0.284
202303 25.163 104.400 25.838
202306 2.020 105.200 2.058
202309 11.449 106.200 11.557
202312 -10.191 106.800 -10.229
202403 18.642 107.200 18.642

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sysmex  (TSE:6869) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sysmex Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sysmex's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (TSE:6869) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines